XML 33 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Series B Preferred Stock
Common Stock
Additional Paid in Capital
Additional Paid in Capital
Series B Preferred Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balances (in shares) at Dec. 31, 2022     82,653,781        
Beginning balance at Dec. 31, 2022 $ (132,711)   $ 9 $ 513,614   $ 6 $ (646,340)
Increase (decrease) in stockholders' equity [Roll Forward]              
Stock-based compensation $ 14,057     14,057      
Exercise of stock options (in shares) 262,500   262,500        
Exercise of stock options $ 353     353      
Release of restricted stock units (in shares)     1,707,292        
Cancellation of shares used to settle payroll tax withholding (in shares)     (331,559)        
Cancellation of shares used to settle payroll tax withholding (633)     (633)      
Issuance of common stock (in shares)     114,841,813        
Issuance of common stock 237,639   $ 12 237,627      
Accretion of Preferred Stock - related party 0            
Foreign currency translation adjustment 1         1  
Change in fair value of debt - credit risk - related party 0            
Net loss $ (229,506)           (229,506)
Ending balances (in shares) at Dec. 31, 2023 199,133,827   199,133,827        
Ending balance at Dec. 31, 2023 $ (110,800)   $ 21 765,018   7 (875,846)
Increase (decrease) in stockholders' equity [Roll Forward]              
Stock-based compensation 18,533     18,533      
Exercise of warrants (in shares)     4,682,767        
Exercise of warrants $ 16,590     16,590      
Exercise of stock options (in shares) 44,000   44,000        
Exercise of stock options $ 56     56      
Release of restricted stock units (in shares)     2,052,963        
Cancellation of shares used to settle payroll tax withholding (in shares)     (749,875)        
Cancellation of shares used to settle payroll tax withholding (1,228)     (1,228)      
Issuance of common stock (in shares)     16,627,523        
Issuance of common stock 14,089   $ 2 14,087      
Accretion of Preferred Stock - related party (278,330) $ (278,330)     $ (278,330)    
Foreign currency translation adjustment (13)         (13)  
Change in fair value of debt - credit risk - related party (43,490)         (43,490)  
Net loss $ (685,870)           (685,870)
Ending balances (in shares) at Dec. 31, 2024 221,791,205   221,791,205        
Ending balance at Dec. 31, 2024 $ (1,070,463)   $ 23 $ 534,726   $ (43,496) $ (1,561,716)